Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
about
Albumin and multiple sclerosisIron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility MappingIron chelation and multiple sclerosisInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisSeven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory processAdvanced MRI and staging of multiple sclerosis lesionsIron in multiple sclerosis: roles in neurodegeneration and repair.Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of ironMultiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging.Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imagingThe clinical utility of QSM: disease diagnosis, medical management, and surgical planning.Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis.Targeting iron metabolism in drug discovery and deliveryPathogenic implications of distinct patterns of iron and zinc in chronic MS lesionsMultiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.Iron homeostasis: a new job for macrophages in adipose tissue?A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple scleroRelationship between iron accumulation and white matter injury in multiple sclerosis: a case-control studyAspirin and multiple sclerosisMagnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.Magnetic susceptibility contrast variations in multiple sclerosis lesionsMRI in the assessment and monitoring of multiple sclerosis: an update on best practice.The prognostic value of the serum ferritin in a southern Brazilian cohort of patients with Gaucher diseasePersistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRILesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity.Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM)Spring cleaning: time to rethink imaging research lines in MS?Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes.Brain morphology and cortical thickness variations in systemic lupus erythematosus patients: Differences among neurological, psychiatric, and nonneuropsychiatric manifestations.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*-Weighted Imaging at 7.0 Tesla.Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.In Vivo 7T MR Quantitative Susceptibility Mapping Reveals Opposite Susceptibility Contrast between Cortical and White Matter Lesions in Multiple Sclerosis.
P2860
Q26749307-F89E6792-E1A7-466D-8497-4260E863739BQ26771174-102D84D3-9B0D-4B23-A680-30ACD06A208EQ27001743-B305BD88-0F18-46E9-9414-36C4829E9BD8Q28080754-9F768962-1AF3-4CE7-ABDB-D0EFCF087682Q30555643-7F341C19-354E-45DE-B704-9C2987BF820EQ30825494-39CABE82-800D-4B5E-BAD0-FA79D835ABBBQ30835527-9499EF0F-A34B-45F6-BCB4-D0EAA430AE9FQ30843585-6198121F-3E0E-4B28-B99F-C3B50717ECECQ30846734-01761DE0-3240-4BE6-8CCF-2DB1F6C7A3AFQ31015218-6127D819-E496-4C60-BE62-E98A3BEEBA2FQ31140002-9F8C8323-A26C-4FA6-A7E8-2CF0269EFD81Q31146333-5379EB65-21C4-47C2-B77F-D7674783DEEEQ33700473-6BC261B2-795F-4480-86A0-F70D83737EA3Q33757232-2C7F1C16-C8A1-47C3-87E2-B607392BF34DQ33841090-6FF9A4FC-E4E2-4124-B53F-0D4BE470D592Q34607681-07136D37-B219-42E0-A7D4-AC0166498FF2Q34681059-B8C8CF92-17EA-47D2-B667-BF9B60960306Q35044427-AD655BA0-F657-4D75-BD0E-F92A24DEAF81Q35168612-5A7173C4-EE13-49B9-A76B-0446666FB460Q35675082-8045839B-3FCD-4450-9555-30C9027E216AQ35678040-5EC142E1-88CC-4178-97BF-3401EDDDE090Q35694584-2BCC7913-A21F-46B2-92B1-6DC0C1182CACQ36368903-9D97FCA9-2488-4587-9072-2980F9BB311FQ36400004-FE023609-E0AB-4CE7-9100-48FB21B71C25Q36727748-362ACC0F-0A2C-481A-9174-8A39C9728410Q37042300-8C1CB5E5-0B88-4DD2-B144-30CEF119DF34Q37099032-AD88E1E0-9733-4D51-9A4F-D88F35FA54E3Q37172391-A7119617-8280-44B5-88DD-7C9523C2C2E0Q37246750-82660F86-0A96-4346-A63A-4E1985C34854Q37439356-70175621-5DA7-4F41-8099-5C2324087FACQ38653397-277F37FF-9EC3-4D1D-9AAD-DB83566BAAA1Q38708148-807FE30F-CF25-49CF-8BD7-E47CBC426AB5Q38737202-0824D8D4-0018-45E6-A587-3A4637B94604Q38805507-ABE66219-EA8F-4317-866C-F8603FE164FBQ39174890-EEBE8731-3CDB-4677-BDBF-2981B6251B57Q39179797-42DD35FF-1EC6-4D67-BD94-82B8DC362131Q39429910-DDEB5886-F43E-4CBF-A70F-AE9AF8CAC6ACQ41689320-C2B8469C-095D-4573-A425-0FD2F1E8828FQ45175510-E79392AB-2723-4CE1-8F12-00A8D522AEE8Q46147833-33236119-9A9D-4827-B320-88CD45AF3304
P2860
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@ast
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@en
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@en-gb
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@nl
type
label
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@ast
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@en
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@en-gb
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@nl
altLabel
Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions
@en
prefLabel
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@ast
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@en
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@en-gb
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@nl
P2093
P2860
P921
P3181
P1433
P1476
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions
@en
P2093
Aaron Boster
David Pitt
Eashwar Swamy
Grant Yang
Petra Schmalbrock
Veela Mehta
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0057573
P407
P577
2013-01-01T00:00:00Z